Selective isolation of nanog-positive human amniotic mesenchymal cells and differentiation into cardiomyocytes

Adult cardiomyocytes have little ability to regenerate, thus cardiac regeneration therapy represents a potential method for treating severe heart failure. Human amniotic mesenchymal cells (hAMCs) have the potential to be a useful cell source for cardiac regeneration therapy. We attempted to isolate...

Ausführliche Beschreibung